“…Doxorubicin was selected as anticancer drug widely employed to treat leukemia and Hodgkin's lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma, and others [31]. Drug loading was carried out adding aqueous INU-FA and doxorubicin hydrochloride solutions, previously treated with a molar excess of TEA, to the dispersion of Au@citrate [17,20]. The drawing forces that allowed the loading of doxorubicin on Au@INU-FA/Doxo nanoparticles were both physical and chemical interactions.…”